全文获取类型
收费全文 | 355篇 |
免费 | 15篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 63篇 |
妇产科学 | 21篇 |
基础医学 | 27篇 |
口腔科学 | 10篇 |
临床医学 | 24篇 |
内科学 | 88篇 |
皮肤病学 | 3篇 |
神经病学 | 24篇 |
特种医学 | 5篇 |
外科学 | 47篇 |
综合类 | 3篇 |
预防医学 | 10篇 |
眼科学 | 3篇 |
药学 | 16篇 |
肿瘤学 | 18篇 |
出版年
2023年 | 1篇 |
2022年 | 2篇 |
2021年 | 8篇 |
2020年 | 5篇 |
2019年 | 9篇 |
2018年 | 6篇 |
2017年 | 6篇 |
2016年 | 8篇 |
2015年 | 16篇 |
2014年 | 10篇 |
2013年 | 22篇 |
2012年 | 25篇 |
2011年 | 26篇 |
2010年 | 24篇 |
2009年 | 18篇 |
2008年 | 32篇 |
2007年 | 28篇 |
2006年 | 37篇 |
2005年 | 26篇 |
2004年 | 20篇 |
2003年 | 12篇 |
2002年 | 10篇 |
2001年 | 3篇 |
2000年 | 2篇 |
1999年 | 1篇 |
1998年 | 4篇 |
1997年 | 1篇 |
1996年 | 4篇 |
1995年 | 3篇 |
1978年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有371条查询结果,搜索用时 25 毫秒
51.
52.
Incidence of stress urinary incontinence among women in Turkey 总被引:1,自引:0,他引:1
Aydan Biri Elif Durukan Işll Maral Ümit Korucuoğlu Hasan Biri Bülent Týraş Mehmet Ali Bumin 《International urogynecology journal》2006,17(6):604-610
The aim of this study was to determine the incidence of stress urinary incontinence among women at the age of 15 and above who applied to the primary health care centers in Ankara, Turkey. We applied the urinary stress incontinence questionnaire to 2,601 women at the age of 15 or above who consulted to the “mother–child health care and family planning centers” in January 2002. To evaluate the urinary incontinence status with respect to age groups and other risk factors, chi-square test was used. Stress incontinence prevalence was 16.1% in our population. Age was a statistically significant risk factor affecting the incidence of stress incontinence. As the number of gravida increases, the frequency of stress incontinence increases (p<0.05). Presence of a systemic disease was also an important risk factor (p<0.05). Alcohol use and smoking were not found to affect the incidence of urinary stress incontinence (p>0.05). As urinary incontinence greatly influences life quality and social and psychological status of the person, and also creates economic burden, predisposing factors of stress incontinence should be well defined and measures should be taken to encourage women experiencing this problem to visit a doctor and to get an efficient treatment. 相似文献
53.
54.
Cipe FE Dogu F Aytekin C Yuksek M Kendirli T Yildiran A Bozdogan G Karatas D Reisli I Dalva K Arpacı F Ikinciogullari A 《Pediatric transplantation》2012,16(5):451-457
SCID is characterized by profound deficiencies of T and B lymphocytes. HSCT is the only curative treatment for children with SCID. The clinical characteristics and outcome of 30 HLA-haploidentical transplantations in 18 patients (15 SCID, two Omenn syndrome, and one MHC Class II deficiency) are reported here. The age of patients at diagnosis ranged from one and half to nine months (median: four months). The median time was one month between the diagnosis and the time of the initial transplantation. Infused CD34+ stem cell dose was ranged between 7 and 94.2 × 10(6) /kg. Nine of 18 patients were found to be positive for CMV antigenemia at diagnosis; therefore, none of them received a conditioning regimen. The most common complication was graft failure (61%), so repeated transplantations (two to four) were performed in seven patients. The mean time of lymphoid engraftment was 17.5 days (median: 16, range: 11-29 days). Ten of 15 SCID (67%) patients survived with a stable complete donor chimerism. However, all three non-SCID patients died. In conclusion, in the absence of a matched family donor, HLA-haploidentical transplantation from parental donors represents a readily available treatment option especially for patients with SCID, offering a high chance of cure. 相似文献
55.
Greco L Timpone L Abkari A Abu-Zekry M Attard T Bouguerrà F Cullufi P Kansu A Micetic-Turk D Mišak Z Roma E Shamir R Terzic S 《World journal of gastroenterology : WJG》2011,17(45):4971-4978
AIM: To estimate the burden of undiagnosed celiac disease (CD) in the Mediterranean area in terms of morbidity, mortality and health cost. METHODS: For statistics regarding the population of each country in the Mediterranean area, we accessed authoritative international sources (World Bank, World Health Organization and United Nations). The prevalence of CD was obtained for most countries from published reports. An overall prevalence rate of 1% cases/total population was finally estimated to represent the f... 相似文献
56.
The aim of this study was to evaluate the efficacy of interferon alpha (IFN-alpha) and long-term lamivudine therapy in children with chronic hepatitis B and to determine the optimal duration of lamivudine therapy. Thirty-eight HBeAg-positive children simultaneously received IFN-alpha2a 5 MU/m2 to 10 MU/m2 for six months and lamivudine (4 mg/kg/day). Lamivudine was administered until anti-HBe seroconversion and was continued for six months in responders. During the five-year study period, we evaluated the efficacy of treatment, occurrence of YMDD mutants and adverse effects. During the study period, alanine aminotransferase (ALT) normalization, clearance of hepatitis B virus (HBV) DNA, HBeAg/anti-HBeAb, HBsAg/anti-HBsAb seroconversion, and histological response were noted in 27 (71.1%), 14 (36.8%), 13 (34.2%), 2 (5.2%) and 10 (47.9%) patients, respectively. Complete response was determined in 34.2% (13/38), and in 69.2% of these responders, response was achieved within 18 months. Breakthrough and YMDD mutant rates were 65.8% and 55.2%, respectively. Breakthrough time was a median 24 months and was associated with low baseline ALT level (p < 0.01). In conclusion, although lamivudine was used for a longer period, the response rate was not higher than in previous reports. We suggest that 18 months' duration of lamivudine treatment is sufficient for combination therapy. 相似文献
57.
Funda Erol Çipe Tarkan Soygür Figen Doğu Özdemir Erdoğan Gunseli Bozdoğan Aydan İkincioğulları 《Pediatric transplantation》2010,14(6):E79-E82
Çipe Erol F, Soygür T, Do?u F, Erdo?an Ö, Bozdo?an G, ?kincio?ullar? A. Late onset hemorrhagic cystitis in a hematopoietic stem cell recipient: Treatment with intravesical hyaluronic acid.Pediatr Transplantation 2010: 14:E79–E82. © 2009 Wiley Periodicals, Inc. Abstract: HC is a common complication following HSCT. Risk factors include viral infections, cyclophosphamide and busulfan usage, pelvic irradiation, older age at transplantation, allogeneic HSCT and GvHD. The severity of HC ranges from mild hematuria to life‐threatening bleeding. Here, we present a seven‐and‐a‐half‐yr‐old boy with Wiskott‐Aldrich syndrome who experienced a late onset Grade III hemorrhagic cystitis following HSCT from his fully matched sibling. A Grade I GvHD localized to skin developed on day +11 and prednisolone therapy was given between the 11th and 22nd d. Myeloid and platelet engraftments were achieved +13 and +16 d, respectively. A gross hematuria began on the 21st post‐transplant day. The urine cultures for bacterial or fungal organisms were negative. Urine analysis by PCR revealed a CMV viruria. Following systemic ganciclovir treatment, urinary CMV became negative but hemorrhagic cystitis did not improve. Due to the probability of existing BK virus or adenovirus, two doses of cidofovir were administered intravesically. As he continued to have painful hematuria with large clot formations, two doses of intravesical hyaluronic acid were applied. Macroscopic hematuria resolved within four d after the second dose. Complete remission was achieved on day +77. Finally, intravesical administration of hyaluronic acid seems to be effective and safe and can be a promising treatment in patients suffering from severe and late onset HC. 相似文献
58.
59.
60.
Bayazit AK Yalcinkaya F Cakar N Duzova A Bircan Z Bakkaloglu A Canpolat N Kara N Sirin A Ekim M Oner A Akman S Mir S Baskin E Poyrazoglu HM Noyan A Akil I Bakkaloglu S Soylu A 《Pediatric nephrology (Berlin, Germany)》2007,22(9):1327-1333
Renovascular disease accounts for 8–10% of all cases of paediatric hypertension, whereas, in adults, its incidence is approximately
1%. The Turkish Paediatric Hypertension Group aimed to create the first registry database for childhood renovascular hypertension
in Turkey. Twenty of the 28 paediatric nephrology centres in Turkey responded to the survey and reported 45 patients (27 girls,
18 boys) with renovascular hypertension between 1990 and 2005. The age at presentation ranged from 20 days to 17 years. The
mean blood pressure at the diagnosis was 169/110 mmHg. Chief complaints of symptomatic patients were headache (38%), seizure
(18%), epistaxis (4%), growth retardation (4%), cognitive dysfunction (4%), polyuria (2%), palpitation (2%), and hemiplegia
(2%). Renovascular hypertension was found incidentally in 11 children. The diagnosis of renovascular hypertension was established
with conventional angiography in 39 patients, MR angiography in three, CT angiography in two, and captopril diethylene triamine
penta-acetic acid (DTPA) scintigraphy in one patient. Twenty-one children had bilateral renal artery stenosis and 24 had unilateral
renal artery stenosis. Of these, 14 (31%) had fibromuscular dysplasia; 12 (27%) Takayasu’s arteritis; six (13%) neurofibromatosis;
two (5%) Williams syndrome; one (2%) Kawasaki disease; one (2%) mid-aortic syndrome; one (2%) extrinsic compression to the
renal artery, and eight (18%) unspecified bilateral renal artery stenosis. Hypertension was controlled with antihypertensive
drugs in 17 patients. Percutaneous transluminal angioplasty (PTRA) or surgery had to be performed in 28 patients: PTRA in
16 patients, PTRA + surgery in one patient and surgery in 11 patients (four nephrectomies). The importance of vasculitic disease,
especially Takayasu’s arteritis, should not be underestimated in children with renovascular hypertension. 相似文献